← Eichor
Study identifier: NCT06890312 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Timing of Anticoagulant Administration During Radial Access Percutaneous Coronary Intervention: the HERA-PCI Study (Heparin Early for Radial Access Percutaneous Coronary Intervention)

Condition: Coronary Angiography · Percutaneous Coronary Intervention · Radial Artery Occlusion  ·  Sponsor: University Hospital, Strasbourg, France

PhaseNA
Planned participants550
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

While the reduced hemorrhagic risk of radial access for percutaneous coronary intervention compared to femoral access is well-established, its main complication remains radial artery occlusion, which can occur in up to 30% of patients. Anticoagulation is the primary preventive measure recommended in clinical practice to reduce the risk of this complication, typically involving heparin injection during the procedure in most centers. However, data on the effect of the timing of heparin injection are limited. The investigators hypothesize that injection of heparin before sheath insertion may reduce the rate of radial artery occlusion compared with injection after sheath insertion.

This description comes directly from the study's public registry record.

Talk to the study team

Pr Patrick OHLMANN Pr Patrick OHLMANN, Professor  ·  03.69.55.09.53  ·  patrick.ohlmann@chru-strasbourg.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Hôpitaux Universitaires de StrasbourgStrasbourg, Bas-Rhin, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06890312